Analysis of mutations within the cytoplasmic domain of the Moloney murine leukemia virus transmembrane protein

Virology

Volumn 227, Issue 2, 1997, Pages 305-313

  Thomas, Ann ^a   Gray, Kimberly D ^a,b   Roth, Monica J ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; VIRUS FUSION PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE MUTATION; MOLONEY LEUKEMIA ONCOVIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROCESSING; PROTEIN STRUCTURE; RAT;

ANIMALIA; MOLONEY MURINE LEUKEMIA VIRUS; MURINAE; ONCOVIRINAE;

EID: 0031579214     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.8333     Document Type: Article

References (46)

1. Chakarabarti, L., Emerman, M., Tiollais, P., and Sonigo, P. (1989). The cytoplasmic domain of simian immunodeficiency virus transmembrane protein modulates infectivity. J. Virol. 63, 4395-4403.
2. Chernomordik, L., Chanturiya, A. N., Suss-Toby, E., Nora, E., and Zimmerberg, J. (1994). An amphipathic peptide from the C-terminal region of the human immunodeficiency virus envelope glycoprotein causes pore formation in membranes. J. Virol. 68, 7115-7123.
3. Colicelli, J., Lobel, L. I., and Goff, S. P. (1985). A temperature-sensitive mutation constructed by "linker insertion" mutagenesis. Mol. Gen. Genet. 199, 537-539.
4. Dubay, J. W., Roberts, S. J., Hahn, B. H., and Hunter, E. (1992). Truncation of the human immunodeficiency virus type 1 glycoprotein cytoplasmic domain blocks virus infectivity. J. Virol. 66, 6616-6625.
5. Einfeld, D., and Hunter, E. (1988). Oligomeric structure of a prototype retrovirus glycoprotein. Proc. Natl. Acad. Sci. USA 85, 8688-8692.
6. Felkner, R. H., and Roth, M. J. (1992). Mutational analysis of the N-linked glycosylation sites of the SU envelope protein of Moloney murine leukemia virus. J. Virol. 66, 4258-4264.
7. Freed, E. O., and Martin, M. A. (1995). The role of human immunodeficiency virus type 1 envelope glycoproteins in virus infection. J. Biol. Chem. 270, 23883-23886.
8. Freed, E. O., and Martin, M. A. (1996). Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions. J. Virol. 70, 341-351.
9. Gallaher, W. R., Ball, J. M., Garry, R. F., Griffin, M. C., and Montelaro, R. C. (1989). A general model for the transmembrane proteins of HIV and other retroviruses. AIDS Res. Hum. Retroviruses 5, 431-440.
10. Goff, S. P., Traktman, P., and Baltimore, D. (1981). Isolation and properties of Moloney murine leukemia virus mutants: Use of a rapid assay for release of virion reverse transcriptase. J. Virol. 38, 239-248.
11. Granowitz, C., Colicelli, J., and Goff, S. P. (1991). Analysis of mutations in the envelope gene of Moloney murine leukemia virus: Separation of infectivity from superinfection resistance. Virology 183, 545-554.
12. Granowitz, C., Berkowitz, R. D., and Goff, S. P. (1996). Mutations affecting the cytoplasmic domain of the Moloney murine leukemia virus envelope protein: Rapid reversion during replication. Virus Res. 41, 25-42.
13. Gray, K. D., and Roth, M. (1993). Mutational analysis of the envelope gene of Moloney murine leukemia virus. J. Virol. 67, 3489-3496.
14. Green, N., Shinnick, T. M., O. Witte, A. P., Sutcliffe, J. G., and Lerner, R. A. (1981). Sequence specific antibodies show that maturation of Moloney leukemia virus envelope polyprotein involves removal of a COOH-terminal peptide. Proc. Natl. Acad. Sci. USA 78, 6023-6027.
15. Henderson, L. E., Sowder, R., Copeland, T. D., Smythers, G., and Oroszlan, S. (1984). Quantitative separation of murine leukemia virus proteins by reversed-phase high pressure liquid chromatography reveals newly described gag and env cleavage products. J. Virol. 52, 492-500.
16. Heinzel, S. S., Krysan, P. J., Calos, M. P., and DuBridge, R. B. (1988). Use of simian virus 40 replication to amplify Epstein-Barr virus shuttle vectors in human cells. J. Virol. 62, 3738-3746.
17. Hunter, E., and Swanstrom, R. (1990). Retrovirus envelope glycoproteins. Curr. Top. Microbiol. Immunol. 157, 187-253.
18. Jones, J. S., and Risser, R. (1993). Cell fusion induced by the murine leukemia virus envelope glycoprotein. J. Virol. 67, 67-74.
19. Karshin, W. L., Arcement, L. J., Naso, R. B., and Arlinghaus, R. B. (1977). Common precursor for Rauscher leukemia virus gp69/71, p15E, and p12(E). J. Virol. 23, 787-798.
20. Li, X., McDermott, B., Yuan, B., and Goff, S. P. (1996). Homomeric interactions between transmembrane proteins of Moloney murine leukemia virus. J. Virol. 70, 1266-1270.
21. Marsh, M., and Helenius, A. (1989). Virus entry into animal cells. Advan. Virus Res. 36, 107-151.
22. McClure, M. O., Sommerfelt, M. A., Marsh, M., and Weiss, R. A. (1990). The pH independence of mammalian retrovirus infection. J. Gen. Virol. 71, 767-773.
23. McCutchan, J. H., and Pagano, J. S. (1968). Enhancement of infectivity of SV40 deoxyribonucleic acid with DEAE dextran. J. Natl. Cancer Inst. 41, 351-357.
24. Park, B. H., Matuschke, B., Lavi, E., and Gaulton, G. N. (1994). A point mutation in env gene of murine leukemia virus induces syncytium formation and neurologic disease. J. Virol. 68, 7516-7524.
25. Pear, W. S., Nolan, G. P., Acott, M. L., and Baltimore, D. (1993). Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90, 8392-8396.
26. Peredo, C., O'Reilly, L., Gray, K., and Roth, M. J. (1996). Characterization of chimeras between the ecotropic Moloney murine leukemia virus and the amphotropic 4070A envelope proteins. J. Virol. 70, 3142-3152.
27. Perez, L. G., Davis, G. L., and Hunter, E. (1987). Mutants of the Rous sarcoma virus envelope glycoprotein that lack the transmembrane anchor and cytoplasmic domains: Analysis of intracellular transport and assembly into virions. J. Virol. 61, 2981-2988.
28. Pinter, A., and Fleissner, E. (1977). The presence of disulfide-linked gp70-p15(E) complexes in AKR murine leukemia virus. Virology 83, 417-422.
29. Pinter, A., Chen, T.-E., Lowy, A., Cortez, N. G., and Silagi, S. (1986). Ecotropic murine leukemia-induced fusion of murine cells. J. Virol. 57, 1048-1054.
30. Pinter, A., and Fleissner, E. (1979). Structural studies of retroviruses: Characterization of oligomeric complexes of murine and feline leukemia virus envelope and core components formed upon cross-linking. J. Virol. 30, 157-165.
31. Pinter, A., Honnen, W. J., Tung, J-S., O'Donnell, P. V., and Hammerling, U. (1982). Structural domains of endogenous murine leukemia virus gp70s containing specific antigenic determinants defined by monoclonal antibodies. Virology 116, 499-516.
32. Ragheb, J. A., Yu, H., Hoffman, T., and Anderson, W. F. (1995). The amphotropic and ecotropic murine leukemia virus envelope TM subunits are equivalent mediators of direct membrane fusion: Implications for the role of ecotropic envelope and receptor in syncytium formation and viral entry. J. Virol. 69, 7205-7215.
33. Ragheb, J. A., and Anderson, W. F. (1994). pH-Independent murine leukemia virus ecotropic envelope-mediated cell fusion: Implications for the role of the R peptide and p12E TM in viral entry. J. Virol. 68, 3220-3231.
34. Ragheb, J. A., and Anderson, W. F. (1994). Uncoupled expression of Moloney murine leukemia virus envelope propolypeptides SU and TM: A functional analysis of the role of TM domains in viral entry. J. Virol. 68, 3207-3219.
35. Rein, A., Mirro, J., Haynes, J. G., Ernst, S. M., and Nagashima, K. (1994). Function of the cytoplasmic domain of a retroviral transmembrane protein: p15E-p2E cleavage activates the membrane fusion capability of the murine leukemia virus env protein. J. Virol. 68, 1773-1781.
36. Rothman, J. E., and Wieland, F. T. (1996). Protein sorting by transport vesicles. Science 272, 227-234.
37. Rowe, W. P., Pugh, W. E., and Hartley, J. W. (1970). Plaque assay techniques for murine leukemia viruses. Virology 42, 1136-1139.
38. Shinnick, T. M., Lerner, R. A., and Sutcliffe, J. G. (1981). Nucleotide sequence of Moloney murine leukemia virus. Nature 293, 543-548.
39. Soneoka, Y., Cannon, P. M., Ramsdale, E. E., Griffiths, J. C., Romano, G., Kingsman, S. M., and Kingsman, A. J. (1995). A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res. 23, 629-633.
40. Sutcliffe, J. G., Shinnick, T. M., Green, N., Liu, F.-T., Niman, H. L., and Lerner, R. A. (1980). Chemical synthesis of a polypeptide predicted from nucleotide sequence allows detection of a new retroviral gene product. Nature 287, 801-805.
41. Thomas, A., and Roth, M. J. (1995). Analysis of cysteine mutations on the transmembrane protein of Moloney murine leukemia virus. Virology 211, 85-289.
42. Tucker, S. P., Srinivas, R. V., and Compans, R. W. (1991). Molecular domains involved in oligomerization of the Friend murine leukemia virus envelope protein. Virology 185, 710-720.
43. Vzorov, A. N., and Compans, R. W. (1996). Assembly and release of SIV Env proteins with full-length or truncated cytoplasmic domains. Virology 221, 22-33.
44. Willems, L., Gatot, J. S., Mammerickx, M., Portetelle, D., Burny, A., Kerkhofs, P., and Kettmann, R. (1995). The YXXL signaling motifs of the bovine leukemia virus transmembrane protein are required for in vivo infection and maintenance of high viral loads. J. Virol. 69, 4137-4141.
45. Wilson, C. A., Marsh, J. W., and Eiden, M. V. (1992). The requirements for viral entry differ from those for virally induced syncytium formation in NIH/3T3/DTras cells exposed to Moloney murine leukemia virus. J. Virol. 66, 7262-7269.
46. Yang, C., and Compans, R. W. (1996). Analysis of the cell fusion activities of chimeric simian immunodeficiency virus-murine leukemia virus envelope proteins: Inhibitory effects of the Rpeptide. J. Virol. 70, 248-254.